|
2021 VUS Annual Meeting
Monday, October 11, 2021, 7:00 AM to Tuesday, October 12, 2021, 12:30 PM CDT
Category: Events
REGISTRATION FEES
| Member Type |
Pricing |
| VUS Member |
$175.00 |
| VUS Resident/Fellow |
$0.00 |
| Non-Member MD |
$395.00 |
| Non-Member (NPPs, APN, NP, PA, Researchers) |
$75.00 |
| Vanderbilt Staff Nurses and Technicians |
$0.00 |
ACCREDITATION INFORMATION
Vanderbilt Urology Society
2021 Annual Meeting
October 11 – 12, 2021
Accreditation Statement
 In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Vanderbilt Urology Society (VUS). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME)
Amedco LLC designates this live activity for a maximum of 9.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Objectives - After Attending This Program You Should Be Able To
- Review best practices for bladder, testicular, and prostate cancer care for localized disease and advanced disease.
- Review strategies for diagnosis and management of benign urologic disease.
- Discuss the impact on COVID on urologic care: past, present, future.
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
|
First
|
Last
|
Commercial Interest
|
|
John
|
Brock
|
NA
|
|
Rochell
|
Burton
|
Coloplast: Scientific/Medical Advisory Board Member, Allergan: Speakers Bureau
|
|
Sam
|
Chang
|
Nant Cell: Consultant, Fergene: Consultant, Merck: Consultant, BMS: Consultant, Urogen: Consultant, mIR: Consultant, Pfizer: Consultant, Photocure: Consultant
|
|
Gilbert
|
Comola
|
NA
|
|
Nancy
|
Davis
|
Seattle Genetics: Research Grant Site Principal Investigator, Gilead (Immunomedics): Research Grant Site Principal Investigator, Incyte: Research Grant Site Principal Investigator, BMS: Research Grant Site Principal Investigator, Mirati: Research Grant Site Principal Investigator, Astra Zeneca:Research Grant Site Principal Investigator, Merck: Research Grant Site Principal Investigator, Janssen:Scientific/Medical Advisory Board Member, Pfizer: Research Grant Site Principal Investigator, Roche: Research Grant Site Principal Investigator
|
|
Roger
|
Dmochowski
|
NA
|
|
Meredith
|
Donahue
|
NA
|
|
Sarah
|
Flury
|
NA
|
|
Connor
|
Forbes
|
NA
|
|
Stephanie
|
Gleicher
|
NA
|
|
Marybeth
|
Hall
|
NA
|
|
Ryan
|
Hsi
|
National Institutes of Health: Research Grant Overall Principal Investigator
|
|
Gautam
|
Jayram
|
Merck: Scientific/Medical Advisory Board Member, Exact Sciences:Scientific/Medical Advisory Board Member, Photocure:Consultant, Uro17: Consultant, UroGPO: Consultant, Blue Earth: Scientific/Medical Advisory Board Member, Janssen: Consultant,AstraZeneca: Scientific/Medical Advisory Board Member
|
|
Niels
|
Johnsen
|
NA
|
|
Melissa
|
Kaufman
|
Boston Scientific: Research Grant Overall Principal Investigator, Cook Myosite:Research Grant Overall Principal Investigator, Medtronic:Research Grant Site Principal Investigator
|
|
Nicholas
|
Kavoussi
|
NA
|
|
Austin
|
Kirschner
|
Varian Medical Systems: Research Grant Site Principal Investigator
|
|
Michael
|
Koch
|
NA
|
|
Amy
|
Luckenbaugh
|
NA
|
|
Jacob
|
McCoy
|
NA
|
|
Nicole
|
Miller
|
Boston Scientific: Consultant, Karl Storz Endoscopy: Research Grant Site Principal Investigator, Virtuoso Surgical: Consultant, Becton Dickinson: Consultant, Intuitive Surgical: Consultant
|
|
Kelvin
|
Moses
|
Astellas/Pfizer: Speakers Bureau
|
|
Naren
|
Nimmagadda
|
NA
|
|
Thomas
|
Oliver
|
NA
|
|
David
|
Penson
|
NA
|
|
John
|
Pope
|
NA
|
|
Matthew
|
Resnick
|
Embold Health: Employee, Embold Health: Stock Shareholder
|
|
Jennifer
|
Robles
|
NA
|
|
Debbie
|
Roller
|
NA
|
|
Tracy
|
Sandstrom
|
NA
|
|
Kristen
|
Scarpato
|
NA
|
|
Elisabeth
|
Sebesta
|
NA
|
|
Shaan
|
Setia
|
NA
|
|
Woodson
|
Smelser
|
NA
|
|
Joseph
|
Smith
|
NA
|
|
C.J.
|
Stimson
|
NA
|
|
Benjamin
|
Stone
|
NA
|
|
Stacy
|
Tanaka
|
NA
|
|
Abby
|
Taylor
|
NA
|
|
John
|
Thomas
|
NA
|
|
Jeffrey
|
Tosoian
|
LynxDx: Stock Shareholder, LynxDx: Consultant
|
|
Alice
|
Wang
|
NA
|
MEETING SPONSORS
This event would not be possible without the generous support of our industry partners and sponsors.
EXHIBITOR & SPONSORSHIP OPPORTUNITIES
For information about sponsorship opportunities, please contact Denise Castetter at [email protected].
|
Prev Month
View Month
Search
Go to Month
Next Month
Export Event